What Most People Get Wrong About Schizophrenia
The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...
Medscape19h
Hallucinogens Tied to Striking Increased Risk of Schizophrenia Spectrum Disorder
ED visits related to hallucinogen use are linked to a 21-fold increased risk of schizophrenia spectrum disorder, results of a ...
Psychology Today6d
A Whole Person Approach to Psychosis and Schizophrenia
Psychosis affects one's physical, psychological, social, and existential health. Mental health recovery often involves a ...
clinicaladvisor.com19h
High MMP9 Predicts Poor Antipsychotic Treatment Response in Schizophrenia
Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Glial Cells May Influence Depression and Schizophrenia
New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.
FierceBiotech2d
AbbVie's $9B schizophrenia prospect flunks phase 2 trials, handing advantage to BMS
Yet, AbbVie’s emraclidine has floundered where Karuna prospered. AbbVie’s phase 2 trials tested emraclidine as a once-daily, oral monotherapy in adults with schizophrenia experiencing an acute ...